Pippard MJ[au] - Search Results

Year	Number of Results
1976	1
1977	3
1978	2
1979	3
1981	1
1982	4
1983	4
1984	1
1985	2
1986	7
1987	5
1988	8
1989	4
1990	3
1991	2
1992	2
1994	1
1996	1
1997	2
1998	2
2000	2
2001	4
2002	1
2003	1
2005	1
2007	1
2008	1
2009	2
2011	1
2017	1
2022	0

1

Microcytic anaemias in childhood and iron-refractory iron deficiency anaemia.

Pippard MJ. Pippard MJ. Br J Haematol. 2017 Apr;177(2):167-168. doi: 10.1111/bjh.14558. Epub 2017 Feb 17. Br J Haematol. 2017. PMID: 28211569 No abstract available.

2

Desferrioxamine-induced iron excretion in humans.

Pippard MJ. Pippard MJ. Baillieres Clin Haematol. 1989 Apr;2(2):323-43. doi: 10.1016/s0950-3536(89)80020-4. Baillieres Clin Haematol. 1989. PMID: 2660931 Review.

3

Plasma ferritin determination as a diagnostic tool.

Finch CA, Bellotti V, Stray S, Lipschitz DA, Cook JD, Pippard MJ, Huebers HA. Finch CA, et al. Among authors: pippard mj. West J Med. 1986 Nov;145(5):657-63. West J Med. 1986. PMID: 3541387 Free PMC article. Review.

4

Iron homeostasis and the assessment of iron status.

Sherwood RA, Pippard MJ, Peters TJ. Sherwood RA, et al. Among authors: pippard mj. Ann Clin Biochem. 1998 Nov;35 ( Pt 6):693-708. doi: 10.1177/000456329803500601. Ann Clin Biochem. 1998. PMID: 9838982 Review. No abstract available.

5

Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.

Pippard MJ. Pippard MJ. Acta Haematol. 1987;78(2-3):206-11. doi: 10.1159/000205876. Acta Haematol. 1987. PMID: 3120473 Review.

6

Chelation regimens with desferrioxamine.

Pippard MJ, Callender ST, Weatherall DJ. Pippard MJ, et al. Lancet. 1977 May 21;1(8021):1101. doi: 10.1016/s0140-6736(77)92351-0. Lancet. 1977. PMID: 68196 No abstract available.

7

Deferiprone for thalassaemia.

Pippard MJ, Weatherall DJ. Pippard MJ, et al. Lancet. 2000 Oct 21;356(9239):1444-5. doi: 10.1016/S0140-6736(05)74089-7. Lancet. 2000. PMID: 11052617 No abstract available.

8

Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.

Drüeke TB, Bárány P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougall IC, Pippard MJ, Shaldon S, van Wyck D. Drüeke TB, et al. Among authors: pippard mj. Clin Nephrol. 1997 Jul;48(1):1-8. Clin Nephrol. 1997. PMID: 9247771 Review.

9

Iron metabolism in thalassemia.

Pootrakul P, Huebers HA, Finch CA, Pippard MJ, Cazzola M. Pootrakul P, et al. Among authors: pippard mj. Birth Defects Orig Artic Ser. 1988;23(5B):3-8. Birth Defects Orig Artic Ser. 1988. PMID: 3291964 Review. No abstract available.

10

Oral iron chelation therapy for thalassaemia: an uncertain scene.

Pippard MJ, Weatherall DJ. Pippard MJ, et al. Br J Haematol. 2000 Oct;111(1):2-5. doi: 10.1046/j.1365-2141.2000.02406.x. Br J Haematol. 2000. PMID: 11091177 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results